BackZenas BioPharma Overview

Zenas BioPharma Minority Interest

Zenas BioPharma's minority interest is $0.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer trimmed avg / median

Loading

Zenas BioPharma Minority Interest History

Loading

Zenas BioPharma vs. peers: Minority Interest Comparison

Loading

Zenas BioPharma Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zenas BioPharma (ZBIO) FAQ

The latest minority interest for ZBIO is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Zenas BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, ZBIO's minority interest moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zenas BioPharma's operating scale or balance-sheet position.

A minority interest figure of $0 for ZBIO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ZBIO's minority interest ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Zenas BioPharma's minority interest against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.